Miller C - Search Results

1

Utilization of the PEN-FAST Clinical Decision-Making Tool to Update Penicillin Allergies and Identify Low-Risk Patients.

Lam H, Parsels K, Steele JM, Kufel WD, Andrew R, Miller C, Darko W, Seabury R. Lam H, et al. Among authors: miller c. J Pharm Pract. 2024 Nov 19:8971900241302394. doi: 10.1177/08971900241302394. Online ahead of print. J Pharm Pract. 2024. PMID: 39562507 No abstract available.

2

Evaluation of dabigatran utilization and risk among hospitalized patients.

Sidman E, Probst LA, Darko W, Miller CD. Sidman E, et al. Ann Pharmacother. 2014 Mar;48(3):349-53. doi: 10.1177/1060028013513722. Epub 2013 Nov 20. Ann Pharmacother. 2014. PMID: 24259660

3

Are Vancomycin Trough Concentrations of 15 to 20 mg/L Associated With Increased Attainment of an AUC/MIC ≥ 400 in Patients With Presumed MRSA Infection?

Hale CM, Seabury RW, Steele JM, Darko W, Miller CD. Hale CM, et al. J Pharm Pract. 2017 Jun;30(3):329-335. doi: 10.1177/0897190016642692. Epub 2016 Apr 12. J Pharm Pract. 2017. PMID: 27074786

4

Pharmacy impact on medication reconciliation in the medical intensive care unit.

Wills BM, Darko W, Seabury R, Probst LA, Miller CD, Cwikla GM. Wills BM, et al. J Res Pharm Pract. 2016 Apr-Jun;5(2):142-5. doi: 10.4103/2279-042X.179584. J Res Pharm Pract. 2016. PMID: 27162810 Free PMC article.

5

Clinical Application and Pharmacodynamic Monitoring of Apixaban in a Patient with End-Stage Renal Disease Requiring Chronic Hemodialysis.

Kufel WD, Zayac AS, Lehmann DF, Miller CD. Kufel WD, et al. Pharmacotherapy. 2016 Nov;36(11):e166-e171. doi: 10.1002/phar.1836. Epub 2016 Oct 14. Pharmacotherapy. 2016. PMID: 27643979

6

Impact of a pharmacist-driven beta-lactam allergy interview on inpatient antimicrobial therapy: A pilot project.

Sigona NS, Steele JM, Miller CD. Sigona NS, et al. J Am Pharm Assoc (2003). 2016 Nov-Dec;56(6):665-669. doi: 10.1016/j.japh.2016.05.005. Epub 2016 Oct 10. J Am Pharm Assoc (2003). 2016. PMID: 27745795

7

Characterization of Drug-Related Problems Occurring in Patients Receiving Outpatient Antimicrobial Therapy.

Hale CM, Steele JM, Seabury RW, Miller CD. Hale CM, et al. J Pharm Pract. 2017 Dec;30(6):600-605. doi: 10.1177/0897190016688771. Epub 2017 Jan 23. J Pharm Pract. 2017. PMID: 28110617

8

Y-site Incompatibility Between Premix Concentrations of Vancomycin and Piperacillin-Tazobactam: Do Current Compatibility Testing Methodologies Tell the Whole Story?

Kufel WD, Miller CD, Johnson PR, Reid K, Zahra JJ, Seabury RW. Kufel WD, et al. Hosp Pharm. 2017 Feb;52(2):132-137. doi: 10.1310/hpj5202-132. Hosp Pharm. 2017. PMID: 28321140 Free PMC article.

9

Clinical Feasibility of Monitoring Enoxaparin Anti-Xa Concentrations: Are We Getting It Right?

Kufel WD, Seabury RW, Darko W, Probst LA, Miller CD. Kufel WD, et al. Hosp Pharm. 2017 Mar;52(3):214-220. doi: 10.1310/hpj5203-214. Hosp Pharm. 2017. PMID: 28439136 Free PMC article.

10

Impact of a Combination Antibiotic Bag on Compliance With Surviving Sepsis Campaign Goals in Emergency Department Patients With Severe Sepsis and Septic Shock.

Lorenzo MP, MacConaghy L, Miller CD, Meola G, Probst LA, Pratt B, Steele J, Seabury RW. Lorenzo MP, et al. Ann Pharmacother. 2018 Mar;52(3):240-245. doi: 10.1177/1060028017739324. Epub 2017 Oct 27. Ann Pharmacother. 2018. PMID: 29078714

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,676 results

Search Page

Filters